salesforce.com, inc. (NYSE:CRM) Stock Position Increased by Nan Shan Life Insurance Co. Ltd.

Share on StockTwits

Nan Shan Life Insurance Co. Ltd. raised its position in salesforce.com, inc. (NYSE:CRM) by 10.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 723,781 shares of the CRM provider’s stock after purchasing an additional 67,845 shares during the quarter. salesforce.com accounts for approximately 3.0% of Nan Shan Life Insurance Co. Ltd.’s portfolio, making the stock its 6th largest position. Nan Shan Life Insurance Co. Ltd.’s holdings in salesforce.com were worth $107,438,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Chemung Canal Trust Co. raised its position in salesforce.com by 1.2% in the second quarter. Chemung Canal Trust Co. now owns 44,078 shares of the CRM provider’s stock valued at $6,688,000 after purchasing an additional 505 shares during the period. Hills Bank & Trust Co. grew its stake in shares of salesforce.com by 5.3% in the second quarter. Hills Bank & Trust Co. now owns 9,480 shares of the CRM provider’s stock worth $1,438,000 after acquiring an additional 473 shares in the last quarter. Chicago Capital LLC grew its stake in shares of salesforce.com by 3.1% in the second quarter. Chicago Capital LLC now owns 209,748 shares of the CRM provider’s stock worth $31,825,000 after acquiring an additional 6,237 shares in the last quarter. Ibex Wealth Advisors acquired a new position in shares of salesforce.com in the second quarter worth $63,000. Finally, Retirement Systems of Alabama grew its stake in shares of salesforce.com by 1.0% in the second quarter. Retirement Systems of Alabama now owns 612,105 shares of the CRM provider’s stock worth $92,875,000 after acquiring an additional 5,888 shares in the last quarter. 74.11% of the stock is currently owned by institutional investors.

In related news, insider Alexandre Dayon sold 1,452 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $155.57, for a total value of $225,887.64. Following the completion of the sale, the insider now directly owns 50,155 shares of the company’s stock, valued at $7,802,613.35. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Amy E. Weaver sold 5,627 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $141.10, for a total transaction of $793,969.70. Following the completion of the sale, the insider now directly owns 33,316 shares of the company’s stock, valued at $4,700,887.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 250,406 shares of company stock valued at $37,784,327. 5.50% of the stock is owned by corporate insiders.

Shares of CRM stock traded up $1.08 on Tuesday, reaching $162.86. 3,710,319 shares of the stock were exchanged, compared to its average volume of 5,736,937. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 0.31. The business’s 50 day moving average price is $151.13 and its 200 day moving average price is $153.21. The company has a market capitalization of $141.29 billion, a price-to-earnings ratio of 112.32, a PEG ratio of 6.90 and a beta of 1.22. salesforce.com, inc. has a twelve month low of $113.60 and a twelve month high of $167.56.

salesforce.com (NYSE:CRM) last announced its quarterly earnings results on Thursday, August 22nd. The CRM provider reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.57. salesforce.com had a net margin of 6.45% and a return on equity of 7.26%. The firm had revenue of $4 billion during the quarter, compared to analysts’ expectations of $3.96 billion. During the same period in the previous year, the company earned $0.71 earnings per share. salesforce.com’s quarterly revenue was up 21.8% compared to the same quarter last year. Equities research analysts forecast that salesforce.com, inc. will post 1.25 earnings per share for the current year.

Several equities analysts have commented on the stock. Canaccord Genuity boosted their price target on shares of salesforce.com from $175.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, August 23rd. They noted that the move was a valuation call. BMO Capital Markets boosted their price target on shares of salesforce.com from $185.00 to $188.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. KeyCorp set a $180.00 price target on shares of salesforce.com and gave the stock a “buy” rating in a research note on Thursday, August 22nd. JPMorgan Chase & Co. set a $180.00 price target on shares of salesforce.com and gave the stock a “buy” rating in a research note on Friday, August 23rd. Finally, Stephens set a $184.00 price target on shares of salesforce.com and gave the stock a “buy” rating in a research note on Friday, August 23rd. Three equities research analysts have rated the stock with a hold rating, thirty-six have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $184.74.

salesforce.com Profile

salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, and gain insights through analytics and relationship intelligence, as well as deliver quotes, contracts, and invoices.

Featured Article: What is a growth and income fund?

Want to see what other hedge funds are holding CRM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for salesforce.com, inc. (NYSE:CRM).

Institutional Ownership by Quarter for salesforce.com (NYSE:CRM)

Receive News & Ratings for salesforce.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for salesforce.com and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.